解读阿尔多在糖化诱导的糖尿病并发症中的作用
Mayura Apte1, Saee Zambre1, Pratiksha Pisar1
1Symbiosis School of Biological Sciences, Symbiosis International (Deemed University) (SIU), Lavale, Pune, Maharashtra State, India.
先进的糖化终产品 (AGEs) 和阿尔多 (Aldo) 信号有助于糖尿病并发症. 本综述探讨了AGE-RAGE和Aldo-MR通路在糖尿病病和心血管疾病中的未解决的交叉对话.
科学领域:
- 内分泌学和新陈代谢学
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- 糖尿病导致全球的微血管和宏血管并发症.
- 过高血糖驱动先进的糖化终产品 (AGE) 形成,激活AGE受体 (RAGE) 途径,导致炎症,氧化应激和纤维化.
- 高血糖也增加了阿尔多 (Aldo) 分泌,通过矿物质皮质体受体 (MR),通过基因组和非基因组机制促进炎症和纤维化.
研究的目的:
- 审查目前对糖尿病并发症中AGE-RAGE和Aldo-MR途径的理解.
- 为了调查这两个关键路径之间的未解决的交叉对话.
- 突出在糖尿病病 (DN) 和心血管疾病 (CVD) 中治疗干预的潜在相互分子标.
主要方法:
- 对AGE-RAGE和Aldo-MR通路的现有研究进行文献综述.
- 对调查糖化和阿尔多激素信号传递之间的相互作用的研究进行分析.
- 专注于分子机制和临床意义.
主要成果:
- 无论是AGE-RAGE和Aldo-MR通路都是独立地参与DN和心血管疾病的发病.
- 有证据表明,这些途径之间存在显著的相互作用和相互影响.
- 交叉谈话的确切性质仍然不完全阐明.
结论:
- 了解AGE-RAGE和Aldo-MR通路之间的交叉对话对于开发糖尿病并发症的有效疗法至关重要.
- 针对这些相互连接的途径可能为DN和CVD提供新的治疗策略.
- 需要进一步的研究,以充分阐明分子相互作用和临床影响.
更多相关视频
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Oral Hypoglycemic Agents: Biguanides and Glitazones
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
